MacEachern Symposium

Keynote Lecture
“Revolutionizing Tomorrow’s Healthcare Delivery from Technological, Scientific and Quality Improvements Today”

We are in the midst of a revolution in healthcare … and it’s happening on several fronts, in the life sciences, in pharma and in innovative new devices and procedures, health systems and in the newly empowered healthcare consumer. New technologies have changed the ways in which we communicate, both in our public and private lives. Cell phones, pagers, the computer, e-mail and the internet can increase our productivity by making us more accessible and information more readily available. Technological advances are also aiding in new discoveries in the life sciences – especially pharmaceuticals, biotech, new devices and diagnostics, and genomics.

This year’s MacEachern Symposium will explore those frontiers and their implications for a lot of forces in the healthcare equation, those hazy areas where these forces collide and where the rules and economics are being worked out such as, how these changes will be funded and what they will mean to the established players. Things are moving at lightening speed, but what does this mean for the healthcare system and for the many constituencies within the healthcare framework. We have asked many leaders of these constituencies to join us in discussing how they see healthcare’s future taking shape.

To start our 60th Anniversary program, we have asked Michael Sachs back to prognosticate and to explain what changes technology will have down the line and what disruptions they will make. Mr. Sachs previously gave the MacEachern address in 2001.

Michael A. Sachs, Chairman and Founders of SG-2, LLC is a noted health care industry strategist and visionary. SG-2, LLC analyzes the impact of changes in the business and technology of health care. Its clients range from national health care systems to leading academic research institutions, from health plans to medical product suppliers. SG-2 developed The Edge, the first and pre-eminent membership service to examine the significance of new technology for the delivery and economics of health care services.

Prior to founding SG-2, Michael was the Chairman and Founder of Sachs Group, which is now part of Solucient, LLC. Sachs Group, founded in 1984, provided health care planning and marketing data to over 1,000 institutions nationwide. Its market-forecasting tools and target-marketing solutions were recognized as being the most analytically sound and practical in the industry.

Prior to forming Sachs Group, Michael was a consultant with Ernst and Whinney and A.T. Kearney. He served on the management team of Hurley Medical Center in Flint, Michigan. He earned a BA in Science and a MSPH in Health Management from the University of Missouri-Columbia. His health care career began in the Emergency Department of the University of Missouri Medical Center.

A frequent lecturer on the future of health care and the impact of changes on the delivery of care, Michael has presented to executive teams, boards of trustees, industry groups and physicians across the U.S. and abroad. He has contributed articles to journals and magazines and co-authored books and periodicals.

28th Malcolm T. MacEachern Memorial Address

Thomas A. Scully is the Administrator, Centers for Medicare & Medicaid Services in the U.S. Department of Health and Human Services. Mr. Scully was confirmed by the United States Senate and was sworn in as the Administrator of the Centers for Medicare & Medicaid Services (CMS) in May, 2001. As the Administrator of CMS, Tom serves as CEO of the largest health insurance organization in the world. CMS is responsible for the management of Medicare, Medicaid, the State Children’s Health Insurance Program and other national healthcare initiatives. CMS has the second-largest budget outlay of the federal government. The organization is directly responsible for $1 out of every $3 spent on healthcare in the United States. The organization insures approximately 25 percent of the U.S. population – more than 70 million beneficiaries – including the elderly, disabled and some of the lowest income individuals in the country. CMS processes more than 1 billion claims each year and it contracts with approximately 1 million providers.

Prior to assuming responsibility as CMS Administrator, Tom served as President and Chief Executive Officer of the Federation of American Hospitals, the trade association representing the nation’s 1700 privately-owned and managed community hospitals and health systems from January, 1995 to May, 2001.

Previously, Scully was a partner in the Washington, D.C., law firm of Patton Boggs, LLP. His practice focused on regulatory and legislative work in health care. Before joining the law firm, Scully worked at the White House as Deputy Assistant to the President and Counselor to the Director of the Office of Management and Budget (OMB) from 1992-93, and as Associate Director of OMB for Human Resources, Veterans and Labor from 1989-92. In these positions, he oversaw the fiscal policy and regulatory review of the Departments of Health and Human Services, Education, Labor and Veterans Affairs. He also advised President Bush on health care policy, Medicare and Medicaid payment reform.

In 1988, Mr. Scully served on the communications staff of the Bush-Quayle campaign and as Deputy Director of Congressional Affairs for the President-Elect’s transition team. Mr. Scully holds a Juris Doctor degree from Catholic University and a Bachelor’s degree from the University of Virginia.

Following Mr. Scully, we are delighted to welcome back to the podium another previous MacEachern lecturer, Leonard Schaeffer, who gave the Address in 1995.

Leonard D. Schaeffer is Chairman and Chief Executive Officer of WellPoint, one of the nation’s largest publicly traded health care companies. WellPoint serves more than 13 million medical members and more than 49 million specialty members. WellPoint’s 2002 revenues were $17.3 billion.

Mr. Schaeffer joined WellPoint’s predecessor, Blue Cross of California in 1986 as President and CEO. He managed the turnaround of Blue Cross of California and the transition to WellPoint, which is now one of the nation’s most recognized and respected health insurance companies.

Additionally, Mr. Schaeffer led the recapitalization of WellPoint in 1996, resulting in the creation of America’s sixth largest philanthropy with a current endowment of more than $4 billion. WellPoint subsequently increased the value of The Missouri Foundation for Health to nearly $1 billion and endowed a Georgia-based independent charitable foundation with $113.8 million to provide health care services to underserved Georgians.

Previously, Mr. Schaeffer was an executive of Citibank, Group Health, Inc. of Minnesota, and the Student Loan Marketing Association. Under President Carter, he was the administrator of the Health Care Financing Administration (HCFA) in the U.S. Department of Health Education and Welfare (now known as the Department of Health and Human Services). Mr. Schaeffer directed the Bureau of the Budget for the State of Illinois and also served as chairman of the Illinois Capital Development Board and Deputy Director for Management, Illinois Department of Mental Health and Developmental Disabilities.

We will continue following our luncheon with a group of key figures who impact healthcare in a variety of critical ways.

Helen Darling

Helen Darling is President of the Washington Business Group on Health (WBGH), the nation’s only non-profit organization devoted exclusively to providing practical solutions to its members’ most important health care problems and representing large employers’ perspective on national health policy issues. Its 175 members represent more than 40 million employees, retirees and their dependents.

As President of the Business Group, Darling was named one of the “100 Most Powerful People in Health Care in 2003,” by Modern Healthcare. WBGH fosters innovative health benefits decision making among corporate purchasers and helps them share with each other best practices and new solutions to their business problems. A Capitol Hill veteran, Darling works with Congress to advance the understanding of corporate health care issues. She is also President of the Institute on Health Care Costs and Solutions, an organization within WBGH, founded to focus entirely on solutions to the health care cost crisis from a business perspective.

Prior to joining the Business Group, Darling served as Senior Consultant, Group Benefits and Health Care for Watson Wyatt Worldwide. Earlier, for six years, she directed health benefits purchasing for 55,000 employees and retirees at Xerox Corporation. Darling worked in the US Senate as advisor to Senator David Durenberger, the ranking Republican on the Health Subcommittee of the Senate Finance Committee. Darling received her master’s degree in Demography/Sociology and her bachelor’s of science degree in History/English, cum laude, from the University of Memphis.

Bruce E. Bradley is the Director, Health Plan Strategy and Public Policy for Health Care Initiatives for the General Motors Corporation. He is responsible for health care related strategy and public policy, with a focus on quality measurement and improvement, consumer engagement and cost effectiveness.

Bradley joined GM in June, 1996. Prior to that, he spent five years as Corporate Manager, Managed Care for GTE Corporation and nearly 20 years in health plan and HMO management, including 10 years as President and CEO of a large staff model HMO. He also co-founded the HMO Group, a national corporation of 15 non-profit, independent group practice HMOs, and the HMO Group Insurance Co., Ltd.

Bradley has gained broad recognition for his work in achieving health plan quality improvement and for his efforts in developing the Health Employer Data and Information Set (HEDIS) measurements and processes. He is a board member of the National Quality Forum, a member, past chair and co-founder of the Leapfrog Group Board, a member of the board of FACCT, and a past board member of The Academy for Health Services Research and Policy.

A native of Pelham, N.Y., Bradley holds a bachelor’s degree in psychology from Yale University and an MBA in health care administration from the Wharton School at the University of Pennsylvania.

Steven Lazarus is a Managing Director for ARCH Venture Partners and has managed entrepreneurial operations during his career. He has played a key role in the formation and initial funding round of a wide range of companies in the following areas: biotechnology, pharmaceuticals, informatics, medical instrumentation, software, and telecommunications.

From 1986 to 1994, Mr. Lazarus served as President and CEO of ARCH Development Corporation and Associate Dean of the Graduate School of Business of The University of Chicago.

Prior to joining ARCH, Mr. Lazarus was Group Vice President of the Health Care Services Group of Baxter Travenol Laboratories, Inc., now Baxter Healthcare, Inc. During his 13 years at Baxter, he held various positions including Senior Vice President for Technology, which included manufacturing, materials management, research and development, and engineering.

From 1972 to 1974, Mr. Lazarus served in Washington, D.C. as Deputy Assistant Secretary of Commerce for East-West Trade and was the founder and first director of the Bureau of East-West Trade. He is a 21-year veteran of the U.S. Navy, retiring with the rank of Captain in 1973.

Mr. Lazarus is a director of Amgen Corp. (AMGN), Primark Corp. (PMK), First Consulting Group, Inc. (FCGI), and R2 Technology, Inc. He is also a Director of the National Venture Capital Association, and the National Association of Corporate Directors.

He completed his M.B.A. with high distinction at the Harvard Graduate School of Business Administration and received a B.S. with honors from Dartmouth College.